Samsung Electronics has obtained FDA clearance for a listening to assist characteristic constructed straight into appropriate Galaxy Buds for Android customers, following Apple’s mannequin.
Samsung Electronics introduced on Aug 11, 2026, that its Galaxy Buds Listening to Help characteristic has obtained US Meals and Drug Administration (FDA) clearance, enabling appropriate Galaxy Buds to operate as an over-the-counter (OTC) listening to assist for customers 18 years and older with perceived delicate to average listening to loss—with no prescription or clinic go to.
The characteristic joins a broadening phase of shopper units pursuing FDA authorization for OTC hearing aid software, following strikes by different expertise firms, together with Apple, which unveiled hearing aid capabilities for its AirPods Pro in an analogous OTC format. An evaluation of what it means when earbuds are classified as hearing aids has been explored beforehand by The Listening to Evaluate.
Built-in Listening to Take a look at and Personalised Amplification
The Galaxy Buds listening to well being expertise facilities on two options built-in straight into the buds with out requiring a separate app. Customers navigate to the Galaxy Buds menu in gadget Settings to entry a self-administered Listening to Take a look at that takes roughly 5 minutes to finish. Utilizing clinical-grade, pure-tone audiometry, the software program assessments every ear individually and generates an audiogram, with Samsung stating the accuracy is similar to an expert audiologist’s analysis. Outcomes categorize listening to as regular or classify it into one in all 4 phases of listening to loss: delicate, average, extreme, or profound.
The Listening to Take a look at is registered as a software program as a medical gadget (SaMD). Primarily based on take a look at outcomes, the Listening to Help characteristic amplifies sounds the consumer has problem listening to—reminiscent of excessive frequencies, surrounding whispers, and distant voices—customized to every particular person’s listening to profile.
The gadget makes use of NAL-NL2, which, whereas not the most recent, has lengthy been used because the scientific commonplace components for becoming prescription listening to aids, to ship customized amplification targets. Extra options embrace noise elimination and beamforming, which assist focus sounds in entrance of the consumer whereas suppressing background noise—capabilities sometimes present in premium listening to aids. Listening to-related insights, together with noise publicity ranges and Listening to Take a look at outcomes, are additionally accessible inside the Samsung Well being app.
“Listening to well being is an important part of our general well-being, profoundly impacting how we talk, join with family members and interact with the world,” says Hon Pak, senior vp and head of the digital well being workforce for the Cell eXperience (MX) Enterprise at Samsung Electronics, in a launch. “With the newest clearance from the FDA, we’re increasing entry to listening to assist and making proactive care easy by integrating the Listening to Take a look at and Listening to Help performance straight into the Galaxy Buds.”
Medical Improvement and Validation
Samsung’s path to FDA clearance builds on almost six years of listening to expertise improvement. In 2020, the corporate launched a Private Sound Amplification Product (PSAP) characteristic on Galaxy Buds+, and a clinical study of Samsung earbuds as a hearing enhancement device was subsequently printed in The Listening to Evaluate. That PSAP characteristic was clinically validated in 2021 as efficient assist for each day communication for these with listening to loss.
To develop the OTC listening to assist characteristic, Samsung collaborated with the Nationwide Acoustic Laboratories (NAL) and Samsung Medical Middle (SMC). Medical validation research had been performed at Vanderbilt College Medical Middle, San Jose State College, and the College of Memphis.
Market Context
The announcement arrives amid rising consideration to the OTC hearing aid market and broader MarkeTrak data showing shifting consumer patterns in the age of OTCs and wearables. In keeping with the World Well being Group (WHO), greater than 1.5 billion individuals globally expertise some extent of listening to loss—a determine projected to achieve 2.5 billion by 2050. Samsung notes that many who may benefit from listening to aids don’t use them on account of price, social stigma, or restricted entry to skilled care.
Samsung has not but introduced pricing or a particular availability date for the listening to assist characteristic rollout, however has focused This autumn 2026 for availability in the USA.
